Metraipolis › archive › dc_ebae59b55de2

Innate lymphoid cells in the spotlight: from biomarkers to blueprint for innovative immunotherapy — Europe PMC PMID:40963622

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40963622
DOI
10.3389/fimmu.2025.1655730
License (as archived)
solo-consultazione
Archived
2026-11-10T04:16:40.116Z
SHA-256 of the archived text
d73347c4171efcb920a36891909a70ac1a181afe07034db36889466cb1d5185e
Stable URL of this page
https://metraipolis.com/documento/dc_ebae59b55de2

How to cite

Innate lymphoid cells in the spotlight: from biomarkers to blueprint for innovative immunotherapy — Europe PMC PMID:40963622 — Europe PMC (en), https://europepmc.org/article/MED/40963622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebae59b55de2 (Metraipolis archive dc_ebae59b55de2, sha256 d73347c4171efcb920a36891909a70ac1a181afe07034db36889466cb1d5185e)
BibTeX
@misc{dcebae59b55de2,
  title = {Innate lymphoid cells in the spotlight: from biomarkers to blueprint for innovative immunotherapy — Europe PMC PMID:40963622},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40963622},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebae59b55de2; sha256 d73347c4171efcb920a36891909a70ac1a181afe07034db36889466cb1d5185e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40963622. Agents can read the archived copy with the MCP tool read_document.